Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit

Go back to Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit
(NASDAQ: BLTE) Delayed: 168.67 -6.68 (3.81%)
Previous Close $175.35    52 Week High
Open $175.50    52 Week Low
Day High $175.50    P/E N/A 
Day Low $166.60    EPS
Volume 153,821